LEIDOS BIOMEDICAL RESEARCH INC - DISCOVERY AND DEVELOPMENT OF CANCER THERAPEUTICS FOR NEXT PROGRAM

On Jan 13, 2026, Department of Health and Human Services obligated $22,364,766 to LEIDOS BIOMEDICAL RESEARCH INC for discovery and development of cancer therapeutics for next program. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Sep 8, 2027 — approximately 12 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.